Aarti Pharmalabs Ltd. Financials: Quarterly Results
Revenue
562.17
Cr.
PAT
88.34
Cr.
EBITDA
121.20
Cr.
Aarti Pharmalabs Ltd. Q4FY25 Financial Metrics
| Indicator | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 563.78 | 537.78 | 458.03 | 555.49 | 505.77 |
| Total Income From Operations (Cr.) | 563.78 | 537.78 | 458.03 | 555.49 | 505.77 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 121.20 | 110.60 | 77.27 | 78.51 | 100.43 |
| P/L Before Exceptional Items & Tax (Cr.) | 114.62 | 100.63 | 71.77 | 73.68 | 95.75 |
| P/L After Tax from Ordinary Activities (Cr.) | 88.34 | 73.99 | 54.62 | 55.45 | 65.25 |
| Net Profit/Loss For the Period (Cr.) | 88.34 | 73.99 | 54.62 | 55.45 | 65.25 |
| Basic EPS | 9.75 | 8.16 | 6.03 | 6.12 | 7.20 |
FAQs
Aarti Pharmalabs Ltd. announced its quarterly results for Q4 FY2025 on May 12, 2025.
In Q4 FY2025, Aarti Pharmalabs Ltd. are as follows:
Revenue: ₹562.17 crore
Net Profit: ₹88.34 crore.
For Q4 FY2025, Aarti Pharmalabs Ltd. posted ₹562.17 crore in revenue and ₹88.34 crore in net profit.
Past quarterly results for Aarti Pharmalabs Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.